Statements (21)
Predicate | Object |
---|---|
gptkbp:instanceOf |
gptkb:biotechnology
|
gptkbp:acquiredBy |
gptkb:Merck_&_Co.
|
gptkbp:acquisitionYear |
2021
|
gptkbp:focusesOn |
immunoregulatory therapeutics
|
gptkbp:foundedYear |
2017
|
gptkbp:founder |
gptkb:Anthony_Coyle
gptkb:Jo_Viney gptkb:John_Sundy gptkb:Patrick_S._Baeuerle |
gptkbp:headquartersLocation |
gptkb:Watertown,_Massachusetts,_United_States
|
https://www.w3.org/2000/01/rdf-schema#label |
Pandion Therapeutics
|
gptkbp:industry |
gptkb:biotechnology
|
gptkbp:notableProduct |
PD-1 agonists
immune modulators |
gptkbp:parentCompany |
gptkb:Merck_&_Co.
|
gptkbp:publiclyTraded |
yes
|
gptkbp:stockExchange |
gptkb:NASDAQ
|
gptkbp:stockSymbol |
gptkb:PAND
|
gptkbp:website |
https://www.pandiontx.com/
|
gptkbp:bfsParent |
gptkb:Arsenal_Yards
|
gptkbp:bfsLayer |
6
|